Support Centre

EU: EFPIA issues statement on Schrems II Case, highlights importance of international data transfers in health sector

The European Federation of Pharmaceutical Industries and Associations ('EFPIA') issued, on 29 July 2020, a statement on the Court Justice of the European Union ('CJEU') ruling of 16 July 2020 in Data Protection Commissioner v. Facebook Ireland Limited, Maximillian Schrems (C-311/18) ('the Schrems II Case'), urging the European authorities to collaborate with US authorities in order to find a long-term basis for transatlantic data transfers and to make elaborate sectoral contractual clauses. In particular, EFPIA highlighted that, in light of the COVID-19 ('Coronavirus') pandemic, disruption to data flows can jeopardise public health and that international data transfers are important for the improvement of treatment, patient safety, monitoring of drug reactions, and enabling innovative therapies.

You can read the statement here.